Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-12-20Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary.
-
CLINICAL_TRIALS study record update · 2012-12-19Clinical Management of Metabolic Problems in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-12-17Intranasal Insulin Treatment in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-12-17A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
-
CLINICAL_TRIALS study record update · 2012-12-13Psychosis in Schizophrenia: Mechanisms of Recovery
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-12-12A Placebo-controlled Cross Study of Panax Ginseng in Augmentation of Antipsychotics in 60 Partially Treatment Responsive Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-12-07Treatment Success in Patients Requiring Treatment Change From Olanzapine to Risperidone Long Acting Injectable (TRESOR)
-
CLINICAL_TRIALS study record update · 2012-12-05Effects of rTMS on Smoking Cessation and Cognitive Outcomes in Outpatients With Schizophrenia Treated With Transdermal Nicotine Patch
-
CLINICAL_TRIALS study record update · 2012-11-30RECONNECT-S GAMMA : A Non-interventional Study to Observe Real-life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-11-29A Proof of Concept, Multi-Center, Randomized, Double-Blind, Parallel, Placebo-Controlled, Study of Zonisamide Sustained Release (SR) 360 mg Versus Placebo in the Prevention of Weight Gain Associated With Olanzapine Therapy for Psychosis
-
CLINICAL_TRIALS study record update · 2012-11-27Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
-
CLINICAL_TRIALS study record update · 2012-11-27Randomized Controlled Trial of The Safety and Efficacy of Aripiprazole VS Ziprasidone in Schizophrenic Patients With Metabolic Syndrome and Diabetes Mellitus.
-
CLINICAL_TRIALS study record update · 2012-11-19Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
-
CLINICAL_TRIALS study record update · 2012-11-08A Double-Blind, Placebo-Controlled, Randomized, Four-Way Cross-Over Study To Investigate Effect Of Single Oral Doses Of JNJ-39393406 On Event-Related Potentials In Subjects With Stable Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-11-05An Open-label, Cross-over Study, to Compare the PET and SPECT Measurement of Antipsychotic-induced D2 Receptor Occupancy, in a Group of Healthy Volunteers and in Another Group of Patients With Schizophrenia and Other Psychotic Disorders
-
CLINICAL_TRIALS study record update · 2012-11-05RECONNECT-S ALPHA: A Non-interventional Study to Observe Real-life Allocation of Antipsychotics in the Acute Inpatient Management of Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-10-25NMDA and Cognitive Remediation in Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-10-24Reduction of Body Weight in Olanzapine Treated Schizophrenia Patients by Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids
-
CLINICAL_TRIALS study record update · 2012-10-24Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)
-
CLINICAL_TRIALS study record update · 2012-10-23Different Safety Profile of Risperidone and Paliperidone Extended-release: a Double-blind, Placebo-controlled Trial With Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2012-10-22An Open-Label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly-Dosed Paliperidone ER Among Treatment-Naïve and Newly Diagnosed Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-10-10Phase I, Randomized, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 579 in Healthy Adult Subjects and Patients With Stable Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2012-10-08An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-10-05A 26-week, Multicenter, Open-label Phase 3b Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in Children and Adolescents With Bipolar I Disorder and Adolescents With Schizophrenia (Abbreviated)
-
CLINICAL_TRIALS study record update · 2012-09-28Effectiveness Trial of Attention Shaping for Schizophrenia